Result of AGM

RNS Number : 0904L

AstraZeneca PLC

29 April 2010

 



ASTRAZENECA PLC

ANNUAL GENERAL MEETING : 29 APRIL 2010

AstraZeneca PLC announced the results of the voting at its Annual General Meeting today.  As proposed in the Notice of AGM, all Resolutions were decided by poll vote.

Resolution 1: Ordinary Resolution to receive the Company's Accounts and the Reports of the Directors and Auditor for the year ended 31 December 2009:

VOTES FOR:            880,212,449 (97.47%)

VOTES AGAINST:    22,873,703 (2.53%)

The Resolution was passed as an Ordinary Resolution.

Resolution 2: Ordinary Resolution to confirm dividends:

VOTES FOR:            904,132,422 (99.99%)

VOTES AGAINST:    78,674 (0.01%)

The Resolution was passed as an Ordinary Resolution.

Resolution 3: Ordinary Resolution to re-appoint KPMG Audit Plc, London as Auditor:

VOTES FOR:            900,380,559 (99.73%)

VOTES AGAINST:    2,407,740 (0.27%)

The Resolution was passed as an Ordinary Resolution.

Resolution 4: Ordinary Resolution to authorise the Directors to agree the remuneration of the Auditor:

VOTES FOR:            901,629,932 (99.87%)

VOTES AGAINST:    1,128,764 (0.13%)

The Resolution was passed as an Ordinary Resolution.

Resolution 5(a): Ordinary Resolution to re-elect Louis Schweitzer as a Director:

VOTES FOR:            858,553,510 (95.86%)

VOTES AGAINST:    37,125,298 (4.14%)

The Resolution was passed as an Ordinary Resolution.

Resolution 5(b): Ordinary Resolution to re-elect David Brennan as a Director:

VOTES FOR:            891,533,604 (99.51%)

VOTES AGAINST:    4,360,891 (0.49%)

The Resolution was passed as an Ordinary Resolution.

Resolution 5(c): Ordinary Resolution to re-elect Simon Lowth as a Director:

VOTES FOR:            892,162,691 (99.72%)

VOTES AGAINST:    2,548,852 (0.28%)

The Resolution was passed as an Ordinary Resolution.

Resolution 5(d): Ordinary Resolution to elect Jean-Philippe Courtois as a Director:

VOTES FOR:            901,489,465 (99.84%)

VOTES AGAINST:    1,489,085 (0.16%)

The Resolution was passed as an Ordinary Resolution.

Resolution 5(e): Ordinary Resolution to re-elect Jane Henney as a Director:

VOTES FOR:            889,580,636 (98.41%)

VOTES AGAINST:    14,406,623 (1.59%)

The Resolution was passed as an Ordinary Resolution.

Resolution 5(f): Ordinary Resolution to re-elect Michele Hooper as a Director:

VOTES FOR:            902,643,793 (99.84%)

VOTES AGAINST:    1,402,670 (0.16%)

The Resolution was passed as an Ordinary Resolution.

Resolution 5(g): Ordinary Resolution to re-elect Rudy Markham as a Director:

VOTES FOR:            861,286,289 (95.27%)

VOTES AGAINST:    42,746,693 (4.73%)

The Resolution was passed as an Ordinary Resolution.

Resolution 5(h): Ordinary Resolution to re-elect Dame Nancy Rothwell as a Director:

VOTES FOR:            889,666,459 (99.72%)

VOTES AGAINST:    2,456,470 (0.28%)

The Resolution was passed as an Ordinary Resolution.

Resolution 5(i): Ordinary Resolution to re-elect John Varley as a Director:

VOTES FOR:            902,382,503 (99.82%)

VOTES AGAINST:    1,646,125 (0.18%)

The Resolution was passed as an Ordinary Resolution.

Resolution 5(j): Ordinary Resolution to re-elect Marcus Wallenberg as a Director:

VOTES FOR:            858,926,295 (95.01%)

VOTES AGAINST:    45,113,576 (4.99%)

The Resolution was passed as an Ordinary Resolution.

Resolution 6: Ordinary Resolution to approve the Directors' Remuneration Report for the year ended 31 December 2009:

VOTES FOR:            812,323,772 (95.93%)

VOTES AGAINST:    34,430,763 (4.07%)

The Resolution was passed as an Ordinary Resolution.

Resolution 7: Ordinary Resolution to authorise limited EU political donations:

VOTES FOR:            879,914,915 (98.35%)

VOTES AGAINST:    14,767,567 (1.65%)

The Resolution was passed as an Ordinary Resolution.

Resolution 8: Ordinary Resolution to authorise the Directors to allot shares:

VOTES FOR:            883,271,101 (98.22%)

VOTES AGAINST:    16,014,678 (1.78%)

The Resolution was passed as an Ordinary Resolution.

Resolution 9: Special Resolution to authorise the Directors to disapply pre-emption rights:

VOTES FOR:            899,439,826 (99.52%)

VOTES AGAINST:    4,305,473 (0.48%)

The Resolution was passed as a Special Resolution.

Resolution 10: Special Resolution to authorise the Company to purchase its own shares:

VOTES FOR:            901,788,245 (99.80%)

VOTES AGAINST:    1,833,197 (0.20%)

The Resolution was passed as a Special Resolution.

Resolution 11: Special Resolution to reduce notice period for general meetings:

VOTES FOR:            819,619,605 (90.67%)

VOTES AGAINST:    84,323,904 (9.33%)

The Resolution was passed as a Special Resolution.

Resolution 12: Special Resolution to adopt new Articles of Association:

VOTES FOR:            851,736,127 (94.38%)

VOTES AGAINST:    50,740,210 (5.62%)

The Resolution was passed as a Special Resolution.

Resolution 13: Ordinary Resolution to approve the AstraZeneca Investment Plan:

VOTES FOR:            674,219,170 (87.52%)

VOTES AGAINST:    96,123,208 (12.48%)

The Resolution was passed as an Ordinary Resolution.

AstraZeneca also announced that, following John Buchanan's departure from the Board, Michele Hooper has been appointed by the Board as Chairman of the Audit Committee.

A C N Kemp

Company Secretary

29 April 2010

 

END

 

 

RAGPGUGGCUPUGMB